
What is the best way to engage people impacted by cognitive disorders in research? Antidote partnered with the BrightFocus Foundation and PatientPoint to survey more than 650 cognitive disorder patients and care partners. Findings reveal:
Understanding trends related to diagnosis and research participation decision-making is critical for cognitive development researchers in their search for new treatments and therapies.
Download the whitepaper to learn more.

Download the whitepaper to learn more.